Chronic Lymphocytic Leukemia Research Consortium Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2003
NCT00800943
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Director, Chronic Lymphocytic Leukemia Research Consortium